Main Menu

ICR and Imperial Convergence Science PhD programme 

Convergence Science PhD Programme 2021-22

Deadline: 23:55 on 24 March 2022

The CRUK Convergence Science Centre at The Institute of Cancer Research and Imperial College London is pleased to announce that funding is available for several prestigious PhD studentships commencing October 2022. We invite applications from talented UK graduates or final year undergraduates from a life science, chemistry, engineering, or physics background.

Convergence Science PhDs cover tuition fees for UK students only except where otherwise stated in the project specification; however, international students are also invited to apply subject to outlining how they will meet the difference in tuition fees.

We look forward to receiving applications from all candidates and will select those who display the potential to become world leading researchers of the future based on their application and performance at an interview. We are encouraging applications from candidates of Black and ethnic minority backgrounds as they are underrepresented at PhD level within the ICR and Imperial.

Candidates should hold, or expect to hold, either

  • a First or upper-second class honours degree (or equivalent) in a relevant subject; or
  • a master’s degree in a relevant subject.

Successful candidates will undertake a four-year research training programme under the guidance of a supervisory team of world-class researchers across the two institutions. Students will receive an annual tax-free stipend, currently £21,000 per annum, and project costs including tuition fees will be underwritten for the four-year duration. 

Available projects

How to apply

Apply now

For questions about the application process please contact

For questions about funding and the programme please contact

PhD studentships

Applications for our main PhD studentships recruitment round are closed.

ICR values

Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.